Piclidenoson

Description: Piclidenoson (CF-101), a selective agonist of adenosine A3 receptor(EC50 values of 0.11 µM), induces robust anti-inflammatory effect in psoriasis patients. Target: Adenosine Receptor, Apoptosis. Smiles: CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(NCc3cccc(I)c3)ncnc12. References: Cohen S , Barer F , Itzhak I , et al. Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A 3 Adenosine Receptor Agonist Piclidenoson[J]. Journal of Immunology Research, 2018, 2018(1):1-8.